https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation
COVID-19 Pregnancy Study Implementation
Methods, Data, & Tools
02/24/2021
Methods, Data, & Tools
02/24/2021
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/ebglyss-lebrikizumab
Assessment of ARIA Sufficiency: Ebglyss (lebrikizumab)
Sufficiency Assessments
04/08/2021
Sufficiency Assessments
04/08/2021
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel
Augmenting Date of Death & Cause of Death Ascertainment in Sentinel
Methods, Data, & Tools
03/16/2022
Methods, Data, & Tools
03/16/2022
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-among-pregnancies-covid-19
Characterizing Medication Use Among Pregnancies with COVID-19 in the Sentinel System
Publications and Presentations
08/26/2022
Publications and Presentations
08/26/2022
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings
Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/identification-obesity-and-tobacco-use-claims-compared
Identification of Obesity and Tobacco Use in Claims Compared to Electronic Health Record (EHR) Data
Publications and Presentations
08/28/2022
Publications and Presentations
08/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/describing-prenatal-exposures-and-evaluating-maternal-and
Describing Prenatal Exposures and Evaluating Maternal and Infant Outcomes in Sentinel
Publications and Presentations
09/13/2022
Publications and Presentations
09/13/2022
https://sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners
Onboarding of Commercial Electronic Health Record (EHR) Data Partners
Methods, Data, & Tools
11/01/2022
Methods, Data, & Tools
11/01/2022
https://sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr
Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment
Methods, Data, & Tools
12/09/2022
Methods, Data, & Tools
12/09/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-patients-and-encounters-trinetx-live-usa
Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis
Analyses
01/12/2023
Analyses
01/12/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant
Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
03/03/2023
Analyses
03/03/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following
Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis
Analyses
03/03/2023
Analyses
03/03/2023
https://sentinelinitiative.org/methods-data-tools/methods/creating-sentinel-linked-electronic-health-record-ehr-claims-development
Creating a Sentinel Linked Electronic Health Record (EHR)-claims Development Network
Methods, Data, & Tools
04/18/2023
Methods, Data, & Tools
04/18/2023
https://sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz
Zarxio (Filgrastim-sndz) & Signal Identification
Studies
06/01/2023
Studies
06/01/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-cannabis-derived-product-users-trinetx-five
Characterization of Cannabis-Derived Product Users in TriNetX: Five Descriptive Analyses
Analyses
07/19/2023
Analyses
07/19/2023
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and
Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System
Publications and Presentations
08/25/2023
Publications and Presentations
08/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles
Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic
Publications and Presentations
08/27/2023
Publications and Presentations
08/27/2023
https://sentinelinitiative.org/news-events/publications-presentations/expanding-capabilities-unapproved-cannabis-derived-product
Expanding Capabilities for Unapproved Cannabis-Derived Product Surveillance in the United States, TriNetX, July 1, 2018 – June 30, 2022
Publications and Presentations
08/27/2023
Publications and Presentations
08/27/2023
https://sentinelinitiative.org/news-events/publications-presentations/unexpected-issues-pharmacoepidemiology-studies-applying
Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes
Publications and Presentations
10/17/2023
Publications and Presentations
10/17/2023
https://sentinelinitiative.org/studies/drugs/ozempic-semaglutide
Ozempic (Semaglutide) & Signal Identification
Studies
10/25/2023
Studies
10/25/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following
Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis
Analyses
11/13/2023
Analyses
11/13/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/medication-use-among-pregnant-patients-covid-19-descriptive
Medication Use Among Pregnant Patients With COVID-19: A Descriptive Analysis
Analyses
01/11/2024
Analyses
01/11/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Signal Identification
Studies
03/18/2024
Studies
03/18/2024
https://sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model
Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies
Publications and Presentations
03/21/2024
Publications and Presentations
03/21/2024
https://sentinelinitiative.org/studies/drugs/new-onset-cancer
New-Onset Cancer & Duration of Follow-up
Studies
03/22/2024
Studies
03/22/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0
Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization
Studies
06/13/2024
Studies
06/13/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes
Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy
Publications and Presentations
06/28/2024
Publications and Presentations
06/28/2024
https://sentinelinitiative.org/studies/drugs/confounding-conditions
Confounding Conditions & Characterization
Studies
08/01/2024
Studies
08/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-neonatal-health-outcomes-among-pregnant
Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
08/02/2024
Analyses
08/02/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant
Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis
Analyses
08/07/2024
Analyses
08/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid
Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis
Analyses
08/08/2024
Analyses
08/08/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparing-risk-adverse-infant-outcomes-among-pregnancies-and
Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/patterns-prescribing-and-dispensing-medicines-among-non
Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prenatal-syphilis-us-characterizing-screening-and-treatment
Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals
Publications and Presentations
08/27/2024
Publications and Presentations
08/27/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-prurigo-nodularis-and
Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis
Analyses
09/03/2024
Analyses
09/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outcome-monitoring-following-guselkumab-use-signal
Outcome Monitoring Following Guselkumab Use: A Signal Identification Analysis
Analyses
09/17/2024
Analyses
09/17/2024
https://sentinelinitiative.org/news-events/publications-presentations/fda-sentinel-real-world-evidence-data-enterprise-rwe-de
The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)
Publications and Presentations
10/10/2024
Publications and Presentations
10/10/2024
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone
Aldactone (spironolactone) & Indications for Use
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/statins-tumor-necrosis-factor-tnf-alpha-inhibitors-granulocyte-colony-stimulating
Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/enterovirus
Enterovirus & Neonatal Enteroviral Sepsis
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/hydroxyurea
Hydroxyurea & Use by Indication
Studies
10/15/2024
Studies
10/15/2024
https://sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use
Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization
Studies
10/16/2024
Studies
10/16/2024
https://sentinelinitiative.org/news-events/publications-presentations/assessing-harmonization-structured-electronic-health-record
Assessing the Harmonization of Structured Electronic Health Record Data to Reference Terminologies and Data Completeness Through Data Provenance
Publications and Presentations
10/21/2024
Publications and Presentations
10/21/2024
https://sentinelinitiative.org/news-events/publications-presentations/letter-editor-considerations-regarding-association
Letter to the Editor: Considerations Regarding Association of Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy
Publications and Presentations
10/31/2024
Publications and Presentations
10/31/2024
https://sentinelinitiative.org/studies/drugs/cannabis
Cannabis & Substance Use Disorder and Poisoning
Studies
11/06/2024
Studies
11/06/2024
https://sentinelinitiative.org/studies/drugs/skyrizi-risankizumab-rzaa
Skyrizi (Risankizumab-Rzaa) & Signal Identification
Studies
11/07/2024
Studies
11/07/2024
https://sentinelinitiative.org/news-events/publications-presentations/enhancing-causes-death-prediction-electronic-health-records
Enhancing Causes of Death Prediction from Electronic Health Records through Multi-Modal Integration of Structured and Unstructured EHR Data
Publications and Presentations
11/13/2024
Publications and Presentations
11/13/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/cancer-rates-among-individuals-loop-diuretics-exposure
Cancer Rates Among Individuals with Loop Diuretics Exposure: A Descriptive Analysis
Analyses
11/14/2024
Analyses
11/14/2024
https://sentinelinitiative.org/studies/drugs/her2-antagonists
HER2 Antagonists & Use in Pregnancy and Oligohydramnios
Studies
11/14/2024
Studies
11/14/2024
https://sentinelinitiative.org/news-events/fda-advisory-committee-meetings/joint-meeting-drug-safety-and-risk-management-1
Joint Meeting of the Drug Safety and Risk Management Advisory Committee and Psychopharmacologic Drugs Advisory Committee Meeting
Regulatory Impact
11/19/2024
Regulatory Impact
11/19/2024
https://sentinelinitiative.org/studies/drugs/individuals-childbearing-potential
Individuals with Childbearing Potential & Conditions Prevalence
Studies
11/21/2024
Studies
11/21/2024
https://sentinelinitiative.org/studies/drugs/new-molecular-entities-nmes
New Molecular Entities (NMEs) & Utilization Characterization
Studies
11/27/2024
Studies
11/27/2024
https://sentinelinitiative.org/studies/drugs/sodium-glucose-co-transporter-2-sglt2-inhibitors-0
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors & Cohort Characterization
Studies
11/27/2024
Studies
11/27/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-users-inclisiran-trinetx-descriptive
Characterization of Users of Inclisiran in TriNetX: A Descriptive Analysis
Analyses
11/27/2024
Analyses
11/27/2024
https://sentinelinitiative.org/studies/drugs/cannabinoid-products
Cannabinoid Products & Cohort Characterization
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/clozapine
Clozapine & Adherence to Absolute Neutrophil Count (ANC) Monitoring and Neutropenia
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-absolute-neutrophil-count-anc-monitoring-and
Occurrence of Absolute Neutrophil Count (ANC) Monitoring and Neutropenia Following Clozapine Use in Patients from Sentinel Data Partners that Curate ANC Laboratory Results: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/occurrence-absolute-neutrophil-count-anc-monitoring-anc-laboratory-results-and-neutropenia
Occurrence of Absolute Neutrophil Count (ANC) Monitoring, ANC Laboratory Results, and Neutropenia Following Clozapine Use: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/corticosteroids-inpatient-utilization
Corticosteroids & Inpatient Utilization
Studies
12/03/2024
Studies
12/03/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/corticosteroid-utilization-patterns-hospitalized-patients
Corticosteroid Utilization Patterns in Hospitalized Patients With and Without a COVID-19 Diagnosis in TriNetX: A Descriptive Analysis
Analyses
12/03/2024
Analyses
12/03/2024
https://sentinelinitiative.org/studies/drugs/pediatric-patients
Pediatric Patients & Hypertension
Studies
12/04/2024
Studies
12/04/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-severe-hyperglycemia-following-systemic-corticosteroids
Risk of Severe Hyperglycemia Following Systemic Corticosteroids and Azithromycin Use in COVID-19 Patients with Type 2 Diabetes: A Sequential Surveillance Analysis
Analyses
12/04/2024
Analyses
12/04/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-hormonal-contraceptives-following-live-birth-or
Utilization of Hormonal Contraceptives Following Live-Birth or Stillbirth Delivery: A Descriptive Analysis
Analyses
12/10/2024
Analyses
12/10/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/clinical-characteristics-incident-users-glucagon-peptide-1
Clinical Characteristics of Incident Users of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/demographic-characteristics-incident-users-selected-non
Demographic Characteristics of Incident Users of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/utilization-selected-non-insulin-antidiabetics-trinetx
Utilization of Selected Non-Insulin Antidiabetics in TriNetX: A Descriptive Analysis
Analyses
12/11/2024
Analyses
12/11/2024
https://sentinelinitiative.org/methods-data-tools/methods/evaluate-use-dance-algorithm-find-disconnected-negative-controls-and
Evaluate the Use of the DANCE Algorithm to Find Disconnected Negative Controls and Develop a Toolkit
Methods, Data, & Tools
12/18/2024
Methods, Data, & Tools
12/18/2024
https://sentinelinitiative.org/methods-data-tools/software-packages-toolkits/centers-medicare-and-medicaid-services-cms-medicaid
The Centers for Medicare and Medicaid Services (CMS): Medicaid and Children’s Health Insurance Program (CHIP) Claims in Sentinel Common Data Model (SCDM) Format
Methods, Data, & Tools
12/18/2024
Methods, Data, & Tools
12/18/2024
https://sentinelinitiative.org/studies/drugs/rinvoq-upadacitinib
Rinvoq (Upadacitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Thrombotic Stroke
Studies
12/20/2024
Studies
12/20/2024
https://sentinelinitiative.org/studies/drugs/olumiant-baricitinib
Olumiant (Baricitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism, and Stroke
Studies
12/20/2024
Studies
12/20/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-dispensing-patterns-baricitinib
Characterization of Dispensing Patterns of Baricitinib, Ritlecitinib, and Upadacitinib in Patients with Alopecia, Crohn's Disease, Ulcerative Colitis, and Inflammatory Bowel Disease: A Descriptive Analysis
Analyses
12/20/2024
Analyses
12/20/2024
https://sentinelinitiative.org/studies/drugs/litfulo-ritlecitinib
Litfulo (Ritlecitinib) & Acute Myocardial Infarction, Deep Vein Thrombosis, Pulmonary Embolism & Stroke
Studies
12/20/2024
Studies
12/20/2024
https://sentinelinitiative.org/studies/drugs/covid-19-pregnancy
COVID-19 in Pregnancy & Drug Utilization, Disease Severity, Adverse Neonatal Outcomes, and Adverse Maternal Outcomes
Studies
12/31/2024
Studies
12/31/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/mometasone-furoate-sinus-implant-use-patients-nasal-polyps-0
Mometasone Furoate Sinus Implant Use in Patients with Nasal Polyps: An Updated Descriptive Analysis
Analyses
12/31/2024
Analyses
12/31/2024
https://sentinelinitiative.org/studies/drugs/sodium-glucose-co-transporter-2-inhibitors-sglt2i
Sodium-Glucose Co-Transporter-2 Inhibitors (SGLT2i) & Factors for Treatment Assignment
Studies
01/07/2025
Studies
01/07/2025
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/cobenfy-xanomeline-tartrate-and
Assessment of ARIA Sufficiency: Cobenfy (xanomeline tartrate and trospium chloride)
Sufficiency Assessments
01/07/2025
Sufficiency Assessments
01/07/2025
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system
Sentinel Routine Querying System
Methods, Data, & Tools
01/10/2025
Methods, Data, & Tools
01/10/2025
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/sentinel-routine-querying-system-reporting-tool
Sentinel Routine Querying System Reporting Tool
Methods, Data, & Tools
01/10/2025
Methods, Data, & Tools
01/10/2025
https://sentinelinitiative.org/studies/drugs/dupixent-dupilumab
Dupixent (Dupilumab) & Signal Identification
Studies
01/13/2025
Studies
01/13/2025
https://sentinelinitiative.org/studies/drugs/individuals-prurigo-nodularis
Individuals with Prurigo Nodularis & Prevalence
Assessments
01/15/2025
Assessments
01/15/2025
https://sentinelinitiative.org/studies/drugs/patients-trinetx-database
Characterization of Patients in the TriNetX Database
Assessments
01/15/2025
Assessments
01/15/2025
https://sentinelinitiative.org/studies/drugs/assessing-arias-ability-evaluate-safety-concern/yorvipath-palopegteriparatide
Assessment of ARIA Sufficiency: Yorvipath (palopegteriparatide)
Sufficiency Assessments
01/15/2025
Sufficiency Assessments
01/15/2025
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/outpatient-utilization-covid-19-treatments-under-emergency
Outpatient Utilization of COVID-19 Treatments Under Emergency Use Authorization (EUA): A Simplified Descriptive Analysis for Paxlovid and other EUA Drugs
Analyses
01/16/2025
Analyses
01/16/2025